AS-605240
Cat. No.：YN420016
CAS No. ：648450-29-7
规格
价格(RMB)
库存
| 产品名称: | AS-605240 |
| CAS No.: | 648450-29-7 |
| Chemical Name: | 5-(6-quinoxalinylmethylene)-2,4-thiazolidinedione |
| Synonyms: | 5-(6-喹噁啉yl亚甲基)-2,4-噻唑烷二酮,AS 605240 |
| 分子量: | 257.27 |
| 分子式: | C₁₂H₇N₃O₂S |
| SMILES: | O=C(NC/1=O)SC1=C/C2=CC=C3N=CC=NC3=C2 |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | AS-605240 是一种口服有效的特异性PI3Kγ抑制剂，IC50值为 8 nM，Ki值为 7.8 nM。 |
| IC50和靶点: | [{name:"PI3Kα:60 nM (IC50)"},{name: "PI3Kβ:270 nM (IC50)"},{name: "PI3Kδ:300 nM (IC50)"},{name: "PI3Kγ:8 nM (IC50)"},{name: "PI3Kγ:7.8 nM (Ki)'}, 'Autophagy'] |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Rameh, L.E., and Cantley, L.C.The role of phosphoinositide 3-kinase lipid products in cell functionJ. Biol. Chem.274(13),8347-8350(1999)
Vivanco, I., and Sawyers, C.L.The phosphatidylinositol 3-kinase-AKT pathway in human cancerNat. Rev. Cancer2(7),489-501(2002)
Hennessy, B.T., Smith, D.L., Ram, P.T., et al.Exploiting the PI3K/AKT pathway for cancer drug discoveryNat. Rev. Drug Discov.4(12),988-1004(2005)
Rückle, T., Schwarz, M.K., and Rommel, C.PI3Kγ inhibition: Towards an 'aspirin of the 21st century'?Nat. Rev. Drug Discov.5(11),903-918(2006)
Camps, M., Rückle, T., Ji, H., et al.Blockade of PI3K g suppresses joint inflammation and damage in mouse models of rheumatoid arthritisNat. Med.11(9),936-943(2005)
